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Running title: Recurrent 2q CNVs 
 
ABSTRACT 
Copy number variation (CNV) in the long arm of chromosome 2 has been implicated in 
developmental delay (DD), intellectual disability (ID), autism spectrum disorder (ASD), 
congenital anomalies, and psychiatric disorders. Here we describe 14 new subjects with recurrent 
deletions and duplications of chromosome 2q11.2, 2q13, and 2q11.2-2q13. Though diverse 
phenotypes are associated with these CNVs, some common features have emerged. Subjects with 
2q11.2 deletions often exhibit DD, speech delay, and attention deficit hyperactivity disorder 
(ADHD), whereas those with 2q11.2 duplications have DD, gastroesophageal reflux, and short 
stature. Congenital heart defects (CHDs), hypotonia, dysmorphic features, and abnormal head 
size are common in those with 2q13 deletions. In the 2q13 duplication cohort, we report 
dysmorphic features, DD, and abnormal head size. Two individuals with large duplications 
spanning 2q11.2–2q13 have dysmorphic features, hypotonia, and DD. This compilation of 
clinical features associated with 2q CNVs provides information that will be useful for healthcare 
providers and for families of affected children. However, the reduced penetrance and variable 
expressivity associated with these recurrent CNVs makes genetic counseling and prediction of 
outcomes challenging.  
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Approximately 15-20% of children referred for chromosomal microarray analysis (CMA) testing 
have a clinically relevant CNV that in many cases explains their phenotype [Cooper et al. 2011; 
Kaminsky et al. 2011; Rudd et al. 2009]. However, for almost all pathogenic CNVs there are a 
range of phenotypic outcomes (variable expressivity) and/or unaffected family members who 
carry the same CNV (incomplete penetrance) [Deak et al. 2011; Moreno-De-Luca et al. 2013; 
Rosenfeld et al. 2013]. Thus, to capture the spectrum of features associated with a new genomic 
disorder, it is essential to evaluate multiple individuals with the same CNV. Deletions and 
duplications mediated by non-allelic homologous recombination (NAHR) are ideal for genotype-
phenotype correlations because they have recurrent breakpoints in unrelated individuals 
[Dittwald et al. 2013; Liu et al. 2011; Stankiewicz and Lupski 2010]. 
Large duplications of the long arm of chromosome 2 have been described in children 
with DD, ID, microcephaly, short stature, and cleft lip and palate [Ounap et al. 2005; Riegel and 
Schinzel 2002]. These duplications were originally identified by chromosome banding and span 
regions as large as 2q11.2-2q21. Five years ago, we reported seven patients with recurrent 
deletions and duplications of 2q11.2 and 2q13 [Rudd et al. 2009]. Based on CNV inheritance, 
normal variation in control CNV datasets, and genes within CNVs, we concluded that 2q11.2 
CNVs were likely pathogenic whereas 2q13 CNVs had unknown clinical significance. Since 
then, similar CNVs have been reported in other studies of DD/ID, ASD, CHD, and schizophrenia 
[Cooper et al. 2011; Costain et al. 2013; Dittwald et al. 2013; Russell et al. 2014; Soemedi et al. 
2012; Yu et al. 2012]. Here we present 14 new subjects with genomic imbalances of 2q11.2– 
2q13 and their phenotypes as compared to published cases, representing the largest study of 
chromosome 2q11.2–2q13 rearrangements to date.  
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MATERIALS AND METHODS 
Human Subjects 
This study was approved by the Institutional Review Boards at Emory University, Baylor 
College of Medicine, and The University of Michigan. Healthcare providers referred families to 
our research study after testing in diagnostic cytogenetics laboratories. We recruited 14 new 
subjects: five with deletions of 2q11.2, three with duplications of 2q11.2, three with deletions of 
2q13, one with a duplication of 2q13, and two with different duplications of the intervening 
region between 2q11.2 and 2q13. We compared the clinical features from new subjects and 
previously reported subjects [Rudd et al. 2009; Russell et al. 2014; Yu et al. 2012]. Subjects 
range in age from six months to 17 years at the time of assessment and have various ethnic 
backgrounds. Informed consent was obtained from probands and their family members. Subjects 
1, 4, 5, 7-10, 12-14 were consented at Emory University, Subjects 2, 3, and 6 were consented at 
Baylor College of Medicine, and Subject 11 was consented at The University of Michigan. Once 
informed consent was provided, medical records and clinical notes were obtained from primary 
care physicians and relevant specialists.  
 
Chromosomal Microarray Analysis (CMA) 
Deletions and duplications were detected by microarray analysis of DNA extracted from 
peripheral blood. Most subjects were tested with a version of the EmArray oligonucleotide array 
[Baldwin et al. 2008]. Agilent microarray design identifier (AMADID) numbers correspond to 
custom array designs (Agilent Technologies, Santa Clara, CA, USA). Subject 10 was tested 
using the EmArray Cyto6000 version 2 (AMADID 0246141) and Subjects 9, 12, and 13 were 
tested with the EmArray Cyto60K (AMADID 0246121); both are based on the NCBI36/hg18 
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genome assembly. Subject 1 was tested using EmArray Cyto (AMADID 0275741), an Oxford 
Gene Technology (OGT) array based on the GRCh37/hg19 genome assembly. Subjects 4-7 were 
tested using the Affymetrix CytoScan HD array and Subjects 11 and 14 were tested using the 
Illumina CytoSNP-850K BeadChip, both based on the GRCh37/hg19 genome assembly. 
Subjects 2 and 3 were tested using the 180k CMA-HR, based on the NCBI36/hg18 genome 
assembly. Coordinates from arrays using the NCBI36/hg18 build were converted to 
GRCh37/hg19 using the LiftOver tool (http://genome.ucsc.edu) [Kent et al. 2002]. 
 DNA digestion, labeling, purification, hybridization, array scanning, and analysis were 
performed following manufacturers’ instructions. To determine the inheritance of CNVs, 
fluorescence in situ hybridization (FISH) analysis was performed on peripheral blood samples 
from parents using standard cytogenetic procedures with probes corresponding to the proband’s 
CNV. 
   
RESULTS 
2q11.2 Deletions 
Speech delay, ADHD, and dysmorphic features are common in children with deletions of 
chromosome 2q11.2 (Fig. 1; Table I). Subject 1’s father carries the 2q11.2 deletion, and 
describes “trouble in school” and two nephews with ADHD. Subject 2’s deletion occurred de 
novo and Subject 3’s deletion was maternally inherited. Subjects 4 and 5 are brothers with the 
same 2q11.2 deletion, but their parents have not been tested. The 2q11.2 deletion is not present 
in databases of normal CNV [Itsara et al. 2009; Macdonald et al. 2014; Shaikh et al. 2009]. 
 
2q11.2 Duplications 
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DD, dysmorphic features, gastroesophageal reflux, and short stature are present in individuals 
with 2q11.2 duplications (Table II). The three children who were assessed exhibited frontal 
bossing with other minor facial features. Subject 6 has begun growth hormone therapy. Her 
mother does not carry the duplication; her father had learning difficulties and short stature, but 
was not available for testing. Subject 7 inherited her duplication from her unaffected mother, and 
her half-brother (Subject 8) carries the same 2q11.2 duplication. Both children have short stature, 
feeding difficulties, and gastroesophageal reflux with vomiting. One duplication of 2q11.2 was 
reported in an individual from the 1000 Genomes project [Consortium et al. 2010]; however, 
2q11.2 duplications are not found in other databases of normal CNV [Itsara et al. 2009; 
Macdonald et al. 2014; Shaikh et al. 2009].  
 
2q13 Deletions 
Eleven subjects have 1.62–1.71-Mb deletions of chromosome 2q13 flanked by the same cluster 
of segmental duplications. Patient 2’s atypical 1.35-Mb deletion partially overlaps the common 
2q13 deletion region, but is shifted distally (Fig. 2) [Russell et al. 2014]. Both regions are distal 
to the smaller 2q13 CNV that includes the NPHP1 gene [Konrad et al. 1996]. Congenital heart 
defects (7/12), dysmorphic features (10/12), hypotonia (7/12), and abnormal head size (9/12) are 
common in those with 2q13 deletions (Table III). Cognitive impairment or ASD was reported in 
4 of the 7 subjects who were evaluated; however, several subjects in our study were less than two 
years of age at the time of assessment so their abilities could not be determined. Five out of eight 
males with 2q13 deletions in our combined studies exhibited hypogonadism or hypospadias 
[Russell et al. 2014; Yu et al. 2012]. One 1.71-Mb deletion of 2q13 has been described in the 
CHOP study of normal CNV [Shaikh et al. 2009], and a similar 2q13 deletion was described in 
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one individual from the Cooper et al. control group [Cooper et al. 2011]. The atypical distal 
deletion of 2q13 has not been described in databases of normal CNV [Russell et al. 2014]. 
 
2q13 Duplications 
Four subjects have a duplication of 2q13 that is reciprocal to the common 2q13 deletion. 
Dysmorphic features, DD, and microcephaly are common findings in this group (Table IV). Two 
of our subjects with 2q13 duplications are members of the same family (Fig. 3). Patient 4 [Rudd 
et al. 2009] has a nephew (Subject 12) with DD, learning disabilities, and dysmorphic features. 
Subject 12’s mother, who also carries the duplication, reported difficulty with math, but strengths 
in expressive language and reading. She also described some difficulties with fine motor skills 
and visual integration. Duplications of this region of chromosome 2q13 are not reported in 
normal CNV databases [Itsara et al. 2009; Macdonald et al. 2014; Shaikh et al. 2009].  
 
2q11.2-2q13 Duplications 
Two subjects have large duplications between the common CNV regions in chromosome 2q11.2 
and 2q13. Subject 13 has a 9.22-Mb duplication of 2q11.2–2q13 (hg19, chr2:102,327,289-
111,548,995) and subject 14 has a 3.33-Mb duplication of 2q12.2–2q13 (hg19, 
chr2:107,132,930-110,465,307) (Fig. 2). The distal breakpoint of both duplications lies in a 
cluster of segmental duplications in 2q13, but the proximal breakpoints are different. Subject 
14’s duplication is flanked by paralogous segmental duplications in 2q12.2 and 2q13, whereas 
Subject 13’s proximal 2q11.2 breakpoint is not bounded by segmental duplications. 
Developmental delay, hypotonia, and various dysmorphic features were present in Subjects 13 
and 14. As for the parents of our subjects who also carry these duplications, Subject 13’s mother 
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reported fainting spells and chest pain with suspected mitral valve prolapse. Subject 14’s father 
is reportedly healthy, though he did not finish high school for unspecified reasons. 
 
DISCUSSION 
In this study, we describe 14 new subjects with pathogenic CNVs involving chromosome 2q11.2, 
2q13, and 2q11.2-2q13 and compare their features to others in the literature. Evaluating multiple 
individuals with the same CNV can shed light on the range of phenotypes associated with a 
deletion or duplication.  
Chromosome 2q13 deletions are the most common CNV in our study, and between our 
subjects and others, a consistent phenotype is beginning to emerge. Dysmorphic features, cranial 
abnormalities, DD, and CHD are the most common features. In all of the families where parents 
were tested, the 2q13 deletion was inherited. However, little or no phenotypic information was 
available from the parents who carried the deletion. The 2q13 deletion is enriched in other 
cohorts of individuals with DD/ID [Bisgaard et al. 2007; Cooper et al. 2011], ASD [Szatmari et 
al. 2007], and CHD [Soemedi et al. 2012] as compared to controls, consistent with a pathogenic 
CNV. Recent knockdown experiments in zebrafish point to two genes involved in the 2q13 
deletion phenotype. Abnormal head size and dysmorphic features may be due to heterozygous 
loss of FBLN7 since depletion of this gene leads to craniofacial defects in fish. In addition, 
knockdown of FBLN7 or TMEM87B individually and synergistically recapitulated heart 
abnormalities in fish [Russell et al. 2014]. 
Dysmorphic features and DD, but not CHDs, are present in those with the reciprocal 
duplication of 2q13. These data suggest that haploinsufficiency, but not triplosensitivity, of 2q13 
cause CHDs. Within Family 3, there is variable expressivity of the 2q13 duplication in three 
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individuals with DD, learning disabilities, and/or dysmorphic features. Duplications of 2q13 
have been reported in other children with DD, congenital anomalies, dysmorphic features, and/or 
ASD [Cooper et al. 2011]. Two subjects with 2q13 duplications have also been described in a 
schizophrenia cohort [Costain et al. 2013]. All three of the subjects in our studies inherited their 
duplications, as did three from Cooper et al., and others have unknown inheritance [Cooper et al. 
2011; Costain et al. 2013; Yu et al. 2012]. In addition, 2q13 duplications are not reported in 
normal CNV databases [Itsara et al. 2009; Macdonald et al. 2014; Shaikh et al. 2009]. This, 
along with the segregation of the duplication in Family 3, suggests that 2q13 duplications are 
pathogenic with variable expressivity. 
Deletions and duplications of 2q11.2 are also considered pathogenic. The 2q11.2 deletion 
is significantly enriched in children with developmental delay as compared to controls [Coe et al. 
2014]. In our cohort, the deletion was inherited from a mildly affected parent (Subject 1), de 
novo (Subject 2), or present in two similarly affected siblings (Family 1), consistent with 
pathogenicity. The 2q11.2 duplication was found to be de novo (Patient 1) or present in siblings 
with similar clinical presentations (Family 2). The short stature observed in all four children with 
2q11.2 duplications is striking and prompted other genetic testing. Subject 7 was referred for 
Russell-Silver testing and Patient 1 was referred for FGFR3 sequencing; both tests were 
negative. 
Dittwald et al. recently described eight patients with deletions of the 2q12.2–2q13 region 
[Dittwald et al. 2013]. These deletions are 502 kb to 1.91 Mb, lie between paralogous segmental 
duplications, and overlap the larger duplications in Subjects 13 and 14. Like Subjects 13 and 14, 
several of the patients with deletions exhibited DD and dysmorphic features. Our Subject 14 and 
Dittwald et al.’s patient 1 have temporal bone narrowing and Subject 13 has dolichocephaly and 
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frontal bossing. Since all three of these CNVs overlap, it is possible that they include a gene 
involved in cranial development. However, none of the genes within the smallest region of 
overlap have been implicated in craniofacial development. Some of the deletions reported by 
Dittwald et al. are present in databases of normal CNV, but the larger duplications in Subjects 13 
and 14 are not [Itsara et al. 2009; Macdonald et al. 2014; Shaikh et al. 2009].  
Like other recurrent CNVs [Deak et al. 2011; Moreno-De-Luca et al. 2013; Rosenfeld et 
al. 2013], deletions and duplications of 2q11.2 and 2q13 exhibit incomplete penetrance and 
variable expressivity. It is possible that parents who carry the same CNV as their affected child 
have milder clinical presentations that were not recognized during childhood. On the other hand, 
affected children may carry additional “second hit” CNVs that exacerbate penetrance of the 
phenotype [Girirajan et al. 2012]. Patient 5 has a 2q13 deletion and an unbalanced translocation 
between chromosomes 1 and 9 [Rudd et al. 2009]. Two patients with 2q13 deletions reported in 
Yu et al. also carry additional CNVs. Case 1 has a 709-kb duplication of chromosome 2p22 and 
Case 3 has a 2.62-Mb duplication of chromosome 22q11.21, which overlaps with the 22q11.2 
Duplication syndrome critical region [Yu et al. 2012]. It is possible that these additional CNVs 
contribute to or modify the phenotypes of those with 2q13 deletions. Since none of the CNVs in 
our study are common in databases of normal variation, it is unlikely that they are benign 
variants without phenotypic consequences.  
Though we have expanded the phenotypes associated with these genomic rearrangements 
of 2q11.2 and 2q13, without a recognizable set of specific features, clinical diagnosis of 
microdeletions and microduplications of the long arm of chromosome 2 is not possible. 
However, this “genotype-first” approach is fast becoming the new standard for diagnosis of 
children with DD/ID, ASD, and congenital anomalies [Watson et al. 2014]. Though these CNVs 
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exhibit variable expressivity, recognizing the spectrum of associated features and conditions is 
helpful for parents and healthcare providers. Detecting clinically relevant CNVs early is 
important to monitor conditions, anticipate future difficulties, and potentially intervene at a 
young age.  
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Fig. 1. Features of subjects with 2q CNVs. Subjects 6-8 have duplications of 2q11.2. A: 
Subject 6 at 10 years. B: Subject 7 at 21 months. C-D: Subject 8 at 21 months and three 
years, respectively. E: Subject 1 (2q11.2 deletion) at four years. F: Subject 12 (2q13 
duplication) at eight years. 
 
Fig. 2. CNVs in chromosome 2q11.1-2q13. Minimum CNV sizes are represented by red 
(deletion) or blue (duplication) bars and segmental duplications are shown below. The 
recurrent NPHP1 deletion/duplication region is shown in green. RefSeq genes (blue) are 
indicated at the bottom. This figure was made with the PDF/PS tool on the UCSC genome 
browser (GRCh37/hg19) [Kent et al. 2002].  
 
Fig. 3. 2q13 duplication family. Variable phenotypes associated with the 2q13 duplication in 
Family 3. Those tested for the duplication are indicated by 2q13 + or 2q13 – for positive and 
negative results, respectively. Subject 12’s brothers and aunt were not tested (NT). 
DD=developmental delay, LD=learning disability, DF=dysmorphic features. 
 
 
 
Table I. Clinical Features of Subjects with Deletions of Chromosome 2q11.2 
 
 Patient 2 Subject 1 Subject 2 Subject 3 Subject 4 
Family 1 
Subject 5 
Family 1 
Totals 
Reference Rudd et al. 
2009 
This study This study This study This study This study  
Age at 
assessment 
16 yrs 4 yrs 4 yrs, 10 
mos 
7 yrs, 1 mos 17 yrs 15 yrs  
Gender M M M F M M  
Ethnicity - Caucasian - Caucasian African 
American 
African 
American 
 
Size of 
CNV 
1.25 Mb 1.25 Mb 913 kb 913 kb 1.61 Mb 1.60 Mb  
Coordinates 96,766,561-
98,013,866 
96,766,565-
98,013,954 
96,739,309-
97,652,262 
96,739,309-
97,652,262 
96,097,383-
97,703,370 
96,097,383-
97,693,317 
 
Inheritance Unknown Paternal De Novo Maternal Unknown, 
familial 
Unknown, 
familial 
 
DD/ID - + + - + + 4/6 
ASD - + - - + + 3/6 
Speech 
delay 
- + + + - + 4/6 
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ADHD + + + + - - 4/6 
Hypotonia - + + - - + 3/6 
Dysmorphic 
features 
 
+  Midface 
hypoplasia, 
coarse 
features, 
hypertelorism, 
depressed 
nasal bridge 
Malformed 
ears, 
midface 
hypoplasia 
Malformed 
ears 
 
- - 4/6 
Skeletal Scoliosis - Pectus 
excavatum  
- Mild scoliosis Kyphoscoliosis, 
kyphosis, 
lordosis, 
microcephaly 
4/6 
Other 
clinical 
findings  
Café-au-lait 
spots, aortic 
coarctation 
Recurrent ear 
infections, hip 
joint 
hypermobility 
Inversion of 
the foot, 
recurrent ear 
infections  
Inversion of 
the foot, 
uncontrolled 
eating  
Encephalopathy, 
sleep problems, 
mood disorder, 
aggression, mild 
motor delays 
Encephalopathy, 
asthma, 
ichthyosis, chiari 
malformation, 
mood disorder, 
aggression 
 
 
 
 
+, feature present; -, feature absent; DD, developmental delay; ID, intellectual 
disability; ASD, autism spectrum disorder; ADHD, attention deficit hyperactivity 
disorder 
 
 
Genomic coordinates for chromosome 2 are based on the GRCh37/hg19 build of the 
human genome. 
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Table II. Clinical Features of Subjects with Duplications of Chromosome 2q11.2 
 
 Patient 1 Subject 6 Subject 7 
Family 2 
Reference Rudd et al. 2009 This study This study 
Age at assessment 16 mos  10 yrs 13 months 
Gender M F F 
Ethnicity Indian Hispanic Caucasian 
Size of CNV 1.47 Mb 1.38 Mb 1.49 Mb 
Coordinates 96,545,351-98,013,866 96,734,646-98,118,200 96,732,520-98,225,552 
Inheritance De Novo Unknown Maternal 
DD/ID + + + 
Hypotonia + - + 
Dysmorphic features +  Prominent forehead, 
flattened nasal bridge, 
protuberant ears 
Prominent forehead, 
triangular face, 
epicanthal folds, short 
philtrum, high arched 
palate 
Short stature + + + 
Skeletal Macrocephaly, 
dolicocephaly, frontal 
bossing 
Microcephaly (2nd%ile), 
scoliosis, frontal bossing 
Frontal bossing, mild leg 
asymmetry 
Gastroesophageal reflux + + + 
Other clinical findings Café-au-lait spots  FTT, low weight 
(<5th%ile), joint pain, 
hypermobility, speech 
delay 
Feeding difficulties, reflux 
with vomiting, FTT, low 
weight (5th%tile), PFO 
Feeding difficulties, reflux 
eosinophilic esophagitis, 
Other cytogenetic 
findings 
inv(Y)(p11.2q11.2)   
 
 
 
FTT, failure to thrive; NA, not assessed; PFO, patent foramen ovale 
 
 
Genomic coordinates for chromosome 2 are based on the GRCh37/hg19 build of the 
human genome. 
 
 
Table III. Clinical Features of Subjects with Deletions of Chromosome 2q13 
 
Au
tho
r M
an
us
cri
pt
CHD, congenital heart defect, TAPVR, total anomalous pulmonary venous return; VSD, ventricular septal defect; PDA, patent 
ductus arteriosis; AVSD, atrioventricular septal defect; HLV, hypoplastic left ventricle; ASD, atrial septal defect; DORV, double 
outlet right ventricle; PA, pulmonary atresia; TOF, tetralogy of fallot; RSAA, right-sided aortic arch; GERD, gastroesophageal 
reflux disorder 
 
 
 Patient 
5 
Patient 
6 
Patient 
7 
Subject 
9 
Subject 
10 
Subject 
11 
Patient 
1 
Patient 
2 
Case 1 Case 2 Case 3 Case 4 To
tal
s 
Refere
nce 
Rudd et 
al. 2009 
Rudd et 
al. 2009 
Rudd et 
al. 2009 
This 
study 
This 
study 
This 
study 
Russell 
et al. 
2014 
Russell 
et al. 
2014 
Yu et 
al. 2012 
Yu et al. 
2012 
Yu et al. 
2012 
Yu et al. 
2012 
 
Age at 
assess
ment 
4 yrs 2 yrs d. <1 yr  <1 yr 5 yrs 6 mos 2 mos  
(d. 6 
mos) 
3 yrs 2 yrs 6 yrs 6 yrs 2 yrs  
Gende
r 
M M M F M M F M F M F M  
Ethnicit
y 
Caucasi
an 
Hispanic Caucasi
an/ 
Hispanic 
Caucasi
an 
Caucasi
an 
Caucasi
an 
African-
America
n 
African-
America
n 
- - - -  
Size of 
CNV 
1.62 Mb 1.62 Mb 1.62 Mb 1.62 Mb 1.62 Mb 1.70 Mb 1.62 Mb 1.35 Mb 1.71 Mb 1.71 Mb 1.71 Mb 1.71 Mb  
Coordi
nates 
111,442,
131-
113,065,
779 
111,442,
131-
113,065,
779 
111,442,
131-
113,065,
779 
111,442
,176-
113,065
,741 
111,44
2,131-
113,06
5,779 
111,675
,789-
113,378
,322 
111,442,
131-
113,065,
779 
112,592,
088-
113,937,
615 
111,392
,198-
113,102
,594 
111,392
,198-
113,102
,594 
111,392
,198-
113,102
,594 
111,392
,198-
113,102
,594 
 
Inherit
ance 
Unknow
n 
Paternal Unknow
n 
Paterna
l 
Paterna
l 
De 
Novo 
Maternal Unknow
n 
Matern
al 
Unknow
n 
Materna
l 
Paternal  
DD/ID NA - NA NA + NA NA + - - + + 4/
7 
ASD NA - NA NA NA NA NA NA - + + NA 2/
4 
Speec
h delay 
- + NA NA + NA NA + - - + - 3/
8 
Hypoto
nia 
- - + - + + + - - + + + 7/
12 
Dysmo
rphic 
feature
s 
+ + + + + - + + + + - + 10
/1
2 
CHD TAPVR, 
VSD, 
PDA, 
heterota
xy, aortic 
coarctati
on 
- VSD, 
PFO,  
2/6 
murmur 
AVSD, 
HLV, 
ASD, 
aortic 
coarctati
on, 
hypopla
stic 
aortic 
arch, 2/6 
murmur 
Ventric
ular 
hypertr
ophy, 
slight 
murmur 
- HLV, 
ASD, 
PDA, 
DORV, 
PA, 2/6 
murmur 
TOF, 
VSD, 
PA, 
RSAA, 
2/6 
murmur 
VSD - - - 7/
12 
Skelet
al 
- - Microce
phaly 
(<1st%ile
) 
Microce
phaly 
(2nd%ile
) 
Microce
phaly 
Macroc
ephaly 
Microcep
haly 
(Slight) 
Microcep
haly 
(Mild), 
absent 
right 5th 
metatars
als/ 
phalang
es 
Macroc
ephaly 
- Macroc
ephaly 
Macroc
ephaly, 
scoliosi
s 
9/
12 
Other 
clinical 
finding
s 
 GERD, 
hypopig
mented 
spots 
Esophag
eal 
atresia, 
hypogon
adism, 
stiff 
joints,  
GERD, 
short 
stature 
(<5th%il
e) 
Dyspha
gia, 
recurre
nt 
bronchit
is, 7th 
nerve 
palsy 
Hyposp
adi s, 
seizure
s, sleep 
apnea 
Cleft 
lip/palate
, stiff 
Joints 
Hypospa
dias, 
broncho
malacia 
Anterior 
anus 
displac
ement, 
hip 
displac
ement 
Hypogo
nadism, 
tall 
stature, 
obesity, 
seizures
, 
panhyp
opituitar
ism 
Lack of 
coordin
ation  
Tall 
stature, 
hypogo
nadism, 
molar 
tooth 
malform
ation 
 
Other 
cytoge
netic 
finding
s 
  der(1)t(1
;9) 
(q43;p21
.3). 
arr[hg18
] 
1q43q44
(237,788
,353)x1,
9p24.3p
21.3(194
,193-
22,0768
57)x3 
     arr[hg1
9] 
2p22(3
2,480,0
16-
33,189,
373)x3 
 arr[hg19
] 
22q11.2
1(17,27
0,271-
19,891,
514)x3 
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Genomic coordinates for chromosome 2 are based on the GRCh37/hg19 build of the human genome. 
 
 
Table IV. Clinical Features of Subjects with Duplications of Chromosome 2q13 
 
 
 
 
Genomic coordinates for chromosome 2 are based on the GRCh37/hg19 build of the 
human genome. 
 
 
 
 
 Patient 3 Patient 4 
Family 3 
Subject 12 
Family 3 
Case 5 Totals 
Reference Rudd et al. 2009 Rudd et al. 2009 This study Yu et al. 2012  
Age at 
assessment 
3 yrs 13 yrs 8 yrs 6 yrs  
Gender M M M M  
Ethnicity Caucasian Caucasian Caucasian -  
Size of CNV 1.62 Mb 1.62 Mb 1.62 Mb 1.71 Mb  
Coordinates 111,442,131-
113,065,779 
111,442,131-
113,065,779 
111,442,131-
113,065,779 
111,392,198-
113,102,594 
 
Inheritance Paternal Paternal Maternal Unknown  
DD/ID + + + + 4/4 
ASD - + - + 2/4 
Hypotonia + - NA + 2/3 
Dysmorphic 
features 
+ + + - 3/4 
Skeletal Microcephaly 
(Mild) 
Microcephaly 
(Mild) 
NA Plagiocephaly 3/3 
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Fig3 . 
 
